Literature DB >> 24802191

Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.

Megan M Tu1, Ahmad Bakur Mahmoud2, Andrew Wight1, Amelia Mottashed1, Simon Bélanger3, Mir Munir A Rahim1, Elias Abou-Samra1, Andrew P Makrigiannis4.   

Abstract

According to the missing-self hypothesis, natural killer (NK) cells survey for target cells that lack MHC-I molecules. The Ly49 receptor family recognizes loss of MHC-I and is critical for educating NK cells, conferring the ability to eliminate transformed or infected cells. In this study, we evaluated their requirement in innate immune surveillance of cancer cells using genetically manipulated mice with attenuated expression of Ly49 receptors (NKC(KD)) in several models of carcinoma and metastasis. We found that NKC(KD) mice exhibited uncontrolled tumor growth and metastases. Expression of two MHC-I alleles, H-2K(b) and H-2D(b), was decreased in tumors from NKC(KD) mice in support of the likelihood of NK-mediated tumor immunoediting. These tumor cells exhibited directed alterations to their cell surface expression in response to the genetically altered immune environment to evade host recognition. Immunoediting in NKC(KD) mice was restricted to MHC-I molecules, which are ligands for Ly49 receptors, while expression of Rae-1 and Mult1, ligands for another NK cell receptor, NKG2D, were unaffected. Restoring NK cell education in NKC(KD) mice with a transgene for the inhibitory self-MHC-I receptor Ly49I restored suppression of cancer onset and growth. Interestingly, immune surveillance mediated by activating Ly49 receptors remained intact in NKC(KD) mice, as demonstrated by the ability to stimulate the NKG2D receptor with tumor cells or splenocytes expressing Rae-1. Together, our results genetically establish the integral role of Ly49 in NK cell-mediated control of carcinogenesis through MHC-I-dependent missing-self recognition. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24802191     DOI: 10.1158/0008-5472.CAN-13-3021

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.

Authors:  Prakash Babu Narasimhan; Tobias Eggert; Yanfang Peipei Zhu; Paola Marcovecchio; Melissa A Meyer; Runpei Wu; Catherine C Hedrick
Journal:  J Immunol       Date:  2019-11-25       Impact factor: 5.422

Review 2.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells.

Authors:  Sourav Paul; Neeraja Kulkarni; Girdhari Lal
Journal:  Oncoimmunology       Date:  2016-09-20       Impact factor: 8.110

4.  Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.

Authors:  Pedro Alves-Peixoto; Maria Férez; Cory J Knudson; Colby Stotesbury; Carolina R Melo-Silva; Eric B Wong; Margarida Correia-Neves; Luis J Sigal
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

5.  Educated natural killer cells show dynamic movement of the activating receptor NKp46 and confinement of the inhibitory receptor Ly49A.

Authors:  Elina Staaf; Per Niklas Hedde; Sunitha Bagawath Singh; Joachim Piguet; Enrico Gratton; Sofia Johansson
Journal:  Sci Signal       Date:  2018-02-13       Impact factor: 8.192

Review 6.  Immunosurveillance and immunotherapy of tumors by innate immune cells.

Authors:  Alexandre Iannello; Thornton W Thompson; Michele Ardolino; Assaf Marcus; David H Raulet
Journal:  Curr Opin Immunol       Date:  2015-12-11       Impact factor: 7.486

7.  Secretory TRAIL-Armed Natural Killer Cell-Based Therapy: In Vitro and In Vivo Colorectal Peritoneal Carcinomatosis Xenograft.

Authors:  Xinxin Song; Se-Hoon Hong; William T Kwon; Lisa M Bailey; Per Basse; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Mol Cancer Ther       Date:  2016-04-12       Impact factor: 6.261

Review 8.  From mice to humans: developments in cancer immunoediting.

Authors:  Michele W L Teng; Jerome Galon; Wolf-Herman Fridman; Mark J Smyth
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

9.  The histone demethylase Kdm6b regulates the maturation and cytotoxicity of TCRαβ+CD8αα+ intestinal intraepithelial lymphocytes.

Authors:  Haohao Zhang; Yiming Hu; Dandan Liu; Zhi Liu; Ningxia Xie; Sanhong Liu; Jie Zhang; Yuhang Jiang; Cuifeng Li; Qi Wang; Xi Chen; Deji Ye; Donglin Sun; Yujia Zhai; Xinhui Yan; Yongzhong Liu; Charlie Degui Chen; Xingxu Huang; Y Eugene Chin; Yufang Shi; Baojin Wu; Xiaoren Zhang
Journal:  Cell Death Differ       Date:  2022-01-09       Impact factor: 12.067

10.  Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.

Authors:  Ahmad Bakur Mahmoud; Megan M Tu; Andrew Wight; Haggag S Zein; Mir Munir A Rahim; Seung-Hwan Lee; Harman S Sekhon; Earl G Brown; Andrew P Makrigiannis
Journal:  PLoS Pathog       Date:  2016-02-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.